期刊文献+

获得性长QT综合征及其易感因素 被引量:5

Acquired long QT syndrome and its predisposing factors
原文传递
导出
摘要 临床上常用的一些药物如抗组胺药、抗微生物药、抗精神病药以及胆碱能拮抗剂等均可诱导获得性长QT综合征(acquired Long QT syndrome,aLQTs)的发生甚至尖端扭转型室性心动过速(Torsades dePointes,TdP)。正常情况下发生概率低,但当存在各种易感因素时发生率增高。主要的易感因素包括致先天性长QT综合征(congenital Long QT syndrome,cLQTs)的基因突变、药物代谢酶遗传多态性,以及药物相互作用、年龄、性别、电解质平衡紊乱等非遗传因素。我们需要正确认识aLQTs发生机理和相关易感因素,进一步构建其遗传背景。 Some drugs, such as antiarrhythmic drugs, antihistamines, antimicrobials, antipsychotics and cholinergic antagonists, can cause acquired long QT syndrome (aLQTs) and Torsades de Pointes (TdP). Although it is rare, the incidence rate becomes higher when several predisposing factors exist. The predisposing factors in- clude mutations that are associated with congenital long QT syndrome (cLQTs), the polymorphisms of drug's meta- bolic enzymes, and non-genetic factors such as drug interaction, age, gender and electrolyte disturbances. Recog- nition of the mechanisms and predisposing factors is necessary for preventing the occurrence of the fatal toxic effect of these drugs. We should establish the genetic background of aLQTs.
出处 《中国新药杂志》 CAS CSCD 北大核心 2013年第7期797-801,共5页 Chinese Journal of New Drugs
关键词 获得性长QT综合征 药物相互作用 基因突变 先天性长QT综合征 药物代谢酶遗传多 态性 acquired long QT syndrome drug interaction gene mutations congenital long QT syndrome polymorphisms of drug's metabolic enzyme
  • 相关文献

参考文献25

  • 1ANTZELEVITCH C. Heterogeneity and cardiac arrhythmias: an overview [ J ]. Heart Rhythm, 2007, 4 (7) :964. 被引量:1
  • 2WONG LC,BEHR ER. Acquired long QT syndrome: as risky as congenital long QT syndrome? [ J]. Europace, 2012, 14 ( 3 ) : 310 -311. 被引量:1
  • 3RODEN DM. Drug-induced prolongation of the QT interval[ J]. N Engl J Med,2004, 350 (10) : 1013 - 1022. 被引量:1
  • 4ICH Harmonized Tripartite Guideline El4. The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for nonantiarrhythmic drugs [ EB/OL]. [ 2005 - 05 - 12 ]. http :// www. fda. gov/eder/guidance/6922fn. 1 htm. 被引量:1
  • 5LEHTONEN A, FODSTAD H, LAITINEN-FORSBLOM P, et al. Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes [ J ]. Heart Rhythm, 2007,4 ( 5 ) :603 - 607. 被引量:1
  • 6赵杰,郑建全.HERG编码的钾离子通道与新药评价[J].军事医学科学院院刊,2005,29(4):386-389. 被引量:4
  • 7JEROEN A, AIMEE DC. Pharmaeogenomics and acquired long QT syndrome [ J ]. Pharmacogeomics, 2005,6 ( 3 ) :259 - 270. 被引量:1
  • 8AERSSENS J, PAULUSSEN AD. Pharmacogenomics and acquired long QT syndrome[ J]. Phama-ogenomics, 2005,6(3) : 259 -270. 被引量:1
  • 9YANG P, KANKI H, DROLET B, et al. Alleric variants in long- QT disease genes in patients with drug-associated torsades de pointes[J]. Circulation, 2002, 105(16) : 1943 - 1948. 被引量:1
  • 10GLAASER IW, KASS RS,CLANCY CE. Mechanisms of genetic arrhythmias : from DNA to ECG [ J ]. Prog Cardiovasc Dis,2003, 46 (3) : 259 - 270. 被引量:1

二级参考文献14

  • 1De Ponti F,Poluzzi E, Montanaro N. QT interval prolongation by non-cardiac drugs: lessons to be learned from recent experience[J]. Eur J Clin Pharmacol, 2000, 56(1): 1-18. 被引量:1
  • 2Tamargo J. Drug-induced torsade de pointes: from molecular biology to bedside[J]. Jpn J Pharmacol, 2000, 83(1): 1-19. 被引量:1
  • 3Petersen CI, McFarland TR, Stepanovic SZ, et al.In vivo identification of genes that modify ether-α-go-go-related gene activity in Caenorhabditis elegans may also affect human cardiac arrhythmia[J]. Proc Natl Acad Sci USA, 2004, 101(32):11773-11778. 被引量:1
  • 4Warmke JW, Ganetzky B. A family of potassium channel genes related to eag in Drosophila and mammals[J]. Proc Natl Acad Sci USA, 1994, 91(8): 3438-344. 被引量:1
  • 5Jiang C, Atkinson D, Towbin JA, et al. Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity[J]. Nat Genet,1994, 8(2): 141. 被引量:1
  • 6Abbott GW, Sesti F, Splawski I, et al.MiRP1 forms Ikr potassium channels with HERG and is associated with cardiac arrhythmia[J]. Cell, 1999, 97(2): 175. 被引量:1
  • 7FU EY, Clemo HF, Ellen Bogen KA. Acquired QT prolongation: mechanism and implication[J]. Cardiol Rev,1998, 6(6): 319-324. 被引量:1
  • 8Roden DM, Spooner PM. Inherited long QT syndromes: A paradigm for understanding arrhythmogenesis[J]. J Cardiovasc Electrophysiol, 1999, 10(12): 1664-1683. 被引量:1
  • 9Netzer R, Ebneth A, Bischoff U, et al.Screening lead compounds for QT interval prolongation[J].Drug Discov Today, 2001, 6(2): 78-84. 被引量:1
  • 10Zhang MQ. Chemistry underlying the cardiotoxicity of antihistamines[J]. Curr Med Chem, 1997,4(3): 171-184. 被引量:1

共引文献3

同被引文献32

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部